These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12431993)

  • 1. Transcription dependence of chromosomal gene targeting by triplex-forming oligonucleotides.
    Macris MA; Glazer PM
    J Biol Chem; 2003 Jan; 278(5):3357-62. PubMed ID: 12431993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting chromosomal sites with locked nucleic acid-modified triplex-forming oligonucleotides: study of efficiency dependence on DNA nuclear environment.
    Brunet E; Corgnali M; Cannata F; Perrouault L; Giovannangeli C
    Nucleic Acids Res; 2006; 34(16):4546-53. PubMed ID: 16951289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of gene expression by triplex-directed psoralen crosslinks.
    Song J; Intody Z; Li M; Wilson JH
    Gene; 2004 Jan; 324():183-90. PubMed ID: 14693383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene.
    Carbone GM; McGuffie E; Napoli S; Flanagan CE; Dembech C; Negri U; Arcamone F; Capobianco ML; Catapano CV
    Nucleic Acids Res; 2004; 32(8):2396-410. PubMed ID: 15121897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of T7 RNA polymerase transcription by phosphate and phosphorothioate triplex-forming oligonucleotides targeted to a R.Y site downstream from the promoter.
    Alunni-Fabbroni M; Manfioletti G; Manzini G; Xodo LE
    Eur J Biochem; 1994 Dec; 226(3):831-9. PubMed ID: 7813472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal mutations induced by triplex-forming oligonucleotides in mammalian cells.
    Vasquez KM; Wang G; Havre PA; Glazer PM
    Nucleic Acids Res; 1999 Feb; 27(4):1176-81. PubMed ID: 9927753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome targeting at short polypurine sites by cationic triplex-forming oligonucleotides.
    Vasquez KM; Dagle JM; Weeks DL; Glazer PM
    J Biol Chem; 2001 Oct; 276(42):38536-41. PubMed ID: 11504712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific inhibition of ICAM-1 expression mediated by gene targeting with Triplex-forming oligonucleotides.
    Besch R; Giovannangeli C; Kammerbauer C; Degitz K
    J Biol Chem; 2002 Sep; 277(36):32473-9. PubMed ID: 12080053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triplex formation by oligonucleotides containing 5-(1-propynyl)-2'-deoxyuridine: decreased magnesium dependence and improved intracellular gene targeting.
    Lacroix L; Lacoste J; Reddoch JF; Mergny JL; Levy DD; Seidman MM; Matteucci MD; Glazer PM
    Biochemistry; 1999 Feb; 38(6):1893-901. PubMed ID: 10026270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide conjugates for chromosomal gene targeting by triplex-forming oligonucleotides.
    Rogers FA; Manoharan M; Rabinovitch P; Ward DC; Glazer PM
    Nucleic Acids Res; 2004; 32(22):6595-604. PubMed ID: 15602001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted correction of an episomal gene in mammalian cells by a short DNA fragment tethered to a triplex-forming oligonucleotide.
    Chan PP; Lin M; Faruqi AF; Powell J; Seidman MM; Glazer PM
    J Biol Chem; 1999 Apr; 274(17):11541-8. PubMed ID: 10206960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-mediated transcription elongation control using triplex-based padlock oligonucleotides.
    Bello-Roufaï M; Roulon T; Escudé C
    Chem Biol; 2004 Apr; 11(4):509-16. PubMed ID: 15123245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved bioactivity of G-rich triplex-forming oligonucleotides containing modified guanine bases.
    Rogers FA; Lloyd JA; Tiwari MK
    Artif DNA PNA XNA; 2014; 5(1):e27792. PubMed ID: 25483840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted gene knockout mediated by triple helix forming oligonucleotides.
    Majumdar A; Khorlin A; Dyatkina N; Lin FL; Powell J; Liu J; Fei Z; Khripine Y; Watanabe KA; George J; Glazer PM; Seidman MM
    Nat Genet; 1998 Oct; 20(2):212-4. PubMed ID: 9771719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoralen photo-cross-linking by triplex-forming oligonucleotides at multiple sites in the human rhodopsin gene.
    Perkins BD; Wensel TG; Vasquez KM; Wilson JH
    Biochemistry; 1999 Sep; 38(39):12850-9. PubMed ID: 10504255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of psoralen DNA crosslinking kinetics associated with a triplex-forming oligonucleotide.
    Oh DH; Suzara V; Krishnan R
    Photochem Photobiol; 2008; 84(3):727-33. PubMed ID: 18435621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of transcription by platinated triplex-forming oligonucleotides.
    Graham MK; Miller PS
    J Biol Inorg Chem; 2012 Dec; 17(8):1197-208. PubMed ID: 22965663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA damage produced by 125I-triplex-forming oligonucleotides as a measure of their successful delivery into cell nuclei.
    Panyutin IV; Sedelnikova OA; Bonner WM; Panyutin IG; Neumann RD
    Ann N Y Acad Sci; 2005 Nov; 1058():140-50. PubMed ID: 16394133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An efficient antigene activity and antiproliferative effect by targeting the Bcl-2 or survivin gene with triplex forming oligonucleotides containing a W-shaped nucleoside analogue (WNA-βT).
    Taniguchi Y; Sasaki S
    Org Biomol Chem; 2012 Oct; 10(41):8336-41. PubMed ID: 22987068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting bcl-2 by triplex-forming oligonucleotide--a promising carrier for gene-radiotherapy.
    Shen C; Rattat D; Buck A; Mehrke G; Polat B; Ribbert H; Schirrmeister H; Mahren B; Matuschek C; Reske SN
    Cancer Biother Radiopharm; 2003 Feb; 18(1):17-26. PubMed ID: 12667305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.